Colorectal cancer screening among government servants in brunei darussalam

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7657-7661

  Chong, Vui Heng ^a   Bakar, Suriawati ^a   Sia, Rusanah ^a   Lee, James ^b,c   Kassim, Norhayati ^b,c   Rajak, Lubna ^b,c   Abdullah, Muhd Syafiq ^a   Chong, Chee Fui ^c  

^a Department of Medicine   (Brunei Darussalam)

^b Ministry of Health   (Brunei Darussalam)

^c RIPAS HOSPITAL   (Brunei Darussalam)

Author keywords

Brunei Darussalam; Colorectal cancer; Compliance; Fecal occult blood; screening colonoscopy

Indexed keywords

ADENOMA; ADULT; ARTICLE; BRUNEI DARUSSALAM; COLONOSCOPY; COLORECTAL TUMOR; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FECES; FEMALE; FOLLOW UP; GOVERNMENT; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PROGNOSIS; SIGMOIDOSCOPY;

ADENOMA; ADULT; BRUNEI; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; FECES; FEMALE; FOLLOW-UP STUDIES; GOVERNMENT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OCCULT BLOOD; PROGNOSIS; SIGMOIDOSCOPY;

EID: 84893402515     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7657     Document Type: Article

References (27)

1. Atkin WS, Edwards R, Kralj-Hans I, et al (2010). UK Flexible sigmoidoscopy trial investigators once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet, 375, 1624-33.
2. Brenner H, Chang-Claude J, Jansen L, et al (2013). Reduced risk of colorectal cancer up to 10 y after screening, surveillance, or diagnostic colonoscopy. Gastroenterology, [Epub ahead of print].
3. Chong VH, Abdullah MS, Telisinghe PU, et al (2009). Colorectal cancer: incidence and trend in Brunei Darussalam. Singapore Med J, 50, 1085-9.
4. Davis T, Arnold C, Rademaker A, et al (2013). Improving colon cancer screening in community clinics. Cancer, [Epub ahead of print].
5. Desch CE, Benson AB 3rd, Somerfield MR, et al (2005). Colorectal cancer surveillance: 2005 update of an american society of clinical oncology practice guideline. J Clin Oncol, 23, 8512-9.
6. th September 2013).
7. Goede SL, van Roon AH, Reijerink JC, et al (2013). Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening. Gut, 62, 727-34.
8. Jerant AF, Fenton JJ, Franks P (2008). Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med, 168, 1317-24.
9. Koo JH, Leong RW, Ching J, et al (2012). Asia pacific working group in colorectal cancer knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc, 76, 126-35.
10. Honein-Abouhaidar GN, Baxter NN, Moineddin R, et al (2013). Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011. Cancer Epidemiol, 37, 946-56.
11. Levin TR, Corley DA (2013). Colorectal-cancer screening-coming of age. N Engl J Med, 369, 1164-6.
12. Levin B, Lieberman DA, McFarland, et al (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology. Gastroenterol, 134, 1570-95.
13. Levy BT, Daly JM, Schmidt EJ, et al (2012). The need for office systems to improve colorectal cancer screening. J Prim Care Community Health, 3, 180-6.
14. Liles EG, Perrin N, Rosales et al (2012). Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care, 18, 588-95.
15. Lin OS (2012). Colorectal cancer screening in patients at moderately increased risk due to family history. World J Gastrointest Oncol, 4, 125-30.
16. Logan RF, Patnick J, Nickerson C, et al (2012). English bowel cancer screening evaluation committee outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut, 61, 1439-46.
17. Mandel JS, Church TR, Bond JH, et al (2000). The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med, 343, 1603-7.
18. Mandel JS, Church TR, Ederer F, et al (1999). Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst, 91, 434-7.
19. Muinuddin A, Aslahi R, Hopman W, et al (2013). Relationship between the number of positive fecal occult blood tests and the diagnostic yield of colonoscopy. Can J Gastroenterol, 27, 90-4.
20. Perencevich M, Ojha RP, Steyerberg EW, et al (2013). Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology, 145, 775-81.
21. Qumseya BJ, Tayem YI, Dasa OY, et al (2013). Colorectal cancer screening in palestine: a national study in a medically underserved population. Clin Gastroenterol Hepatol, 13, 1399-2.
22. Segnan N, Armaroli P, Bonelli L, et al (2011). SCORE working group once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst, 103, 1903.
23. Schoen RE, Pinsky PF, Weissfeld JL, et al (2012). PLCO Project Team Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med, 366, 2345-57.
24. th August 2013).
25. Sung JJ, Lau JY, Young GP, et al (2008). Asia pacific working group on colorectal cancer asia pacific consensus recommendations for colorectal cancer screening. Gut, 57, 1166-76.
26. Shaukat A, Mongin SJ, Geisser MS, et al (2013). Long-term mortality after screening for colorectal cancer. N Engl J Med, 369, 1106-14.
27. von Karsa L, Patnick J, Segnan N, et al (2013). European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy, 45, 51-9.